Richard Parks Medicine shortages have long been an issue, but in recent years, they have reached alarming levels. Essential drugs—such as hormone replacement therapies, cancer treatments, and diabetes medications—have become increasingly difficult to obtain, causing frustration among patients and healthcare providers.
While some shortages have eased, others remain unresolved, highlighting the need for a stronger, coordinated EU response. This has led to the Critical Medicines Act, a legislative initiative designed to strengthen supply chains, improve coordination, and ensure the availability of essential medicines before and during health crises.
Several factors contribute to these disruptions:
- Global instability, including the COVID-19 pandemic, the war in Ukraine, and Brexit
- Surges in demand, often caused by disease outbreaks
- Manufacturing problems, such as recalls, quality issues, or supply chain disruptions
Whatever the cause, these shortages put patients at risk, delaying treatments and creating unnecessary stress for those in need of life-saving medications.
Belgium’s Public Health Minister Frank Vandenbroucke has been a leading advocate for the Critical Medicines Act, pushing for an EU-wide solution to shortages. In May 2023, Belgium called for action, with 23 EU member states supporting the initiative, proving that this issue affects nearly every country in the bloc.
The Critical Medicines Act, expected to take shape in 2025, will focus on:
- Monitoring supply chains to detect and prevent shortages early
- Improving EU coordination to avoid competition between member states over medicine stockpiles
- Reducing reliance on foreign production, as 70-80% of Europe’s pharmaceuticals currently come from China and India
By diversifying production, enhancing EU cooperation, and securing vital medical supplies, the legislation aims to protect millions of patients and ensure Europe’s healthcare systems remain resilient. If successfully implemented, the Critical Medicines Act could mark a turning point in guaranteeing stable drug supplies across the continent.